Structured evidence table for Glycine Cognition Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Glycine Cognition Meta-Analysis | Background Social cognitive impairments are a fundamental aspect of schizophrenia, exerting a substantial influence on patients' functional outcomes. | 1 | Yamada Y (2026) | Pharmacological interventions for social cognitive impairments in schizophrenia: A systematic review and network meta-analysis of randomized controlled trials. |
| Glycine Cognition Meta-Analysis | However, to date, there have been no meta-analyses of comprehensive pharmacological interventions covering all domains of social cognition. | 1 | Yamada Y (2026) | Pharmacological interventions for social cognitive impairments in schizophrenia: A systematic review and network meta-analysis of randomized controlled trials. |
| Glycine Cognition Meta-Analysis | [ ] 7 8 Preclinical and clinical evidence indicate that cisplatin can cross the blood–brain barrier and accumulates in brain regions critical for learning and memory, particularly the hippocampus and prefrontal cortex. | 4 | Kazmi Hafiz Muhammad Obaid (2026) | Neuroprotective effects of glycine against cisplatin-induced cognitive decline in mice |
| Glycine Cognition Meta-Analysis | These molecular and cellular changes translate into impaired synaptic plasticity, reduced neurogenesis, and deficits in spatial learning and memory on standard behavioral tests,. | 4 | Kazmi Hafiz Muhammad Obaid (2026) | Neuroprotective effects of glycine against cisplatin-induced cognitive decline in mice |
| Glycine Cognition Meta-Analysis | We hypothesize that glycine administration will ameliorate cisplatin-associated deficits in spatial learning and working memory and that behavioral protection will align with reduced inflammatory signaling and preserved neuronal integrity. | 4 | Kazmi Hafiz Muhammad Obaid (2026) | Neuroprotective effects of glycine against cisplatin-induced cognitive decline in mice |
| Glycine Cognition Meta-Analysis | [ ] 1 2 Cisplatin, cis-diamminedichloroplatinum II, is one of the most widely used platinum-based chemotherapeutic agents, and it remains a cornerstone treatment for multiple solid tumors including testicular, ovarian, head and neck, lung, and bladder cancers. | 4 | Kazmi Hafiz Muhammad Obaid (2026) | Neuroprotective effects of glycine against cisplatin-induced cognitive decline in mice |
Source documents